- Home
- GILD vs COP Comparison
GILD vs COP Comparison
Compare GILD & COP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GILD
- COP
- Stock Information
- Founded
- GILD 1987
- COP 1917
- Country
- GILD United States
- COP United States
- Employees
- GILD N/A
- COP N/A
- Industry
- GILD Biotechnology: Biological Products (No Diagnostic Substances)
- COP Integrated oil Companies
- Sector
- GILD Health Care
- COP Energy
- Exchange
- GILD Nasdaq
- COP Nasdaq
- Market Cap
- GILD 113.0B
- COP 123.0B
- IPO Year
- GILD 1992
- COP N/A
- Fundamental
- Price
- GILD $93.94
- COP $96.34
- Analyst Decision
- GILD Buy
- COP Buy
- Analyst Count
- GILD 26
- COP 17
- Target Price
- GILD $96.71
- COP $136.25
- AVG Volume (30 Days)
- GILD 7.2M
- COP 8.1M
- Earning Date
- GILD 02-11-2025
- COP 02-06-2025
- Dividend Yield
- GILD 3.28%
- COP 3.21%
- EPS Growth
- GILD N/A
- COP N/A
- EPS
- GILD 0.10
- COP 8.44
- Revenue
- GILD $28,299,000,000.00
- COP $56,924,000,000.00
- Revenue This Year
- GILD $6.50
- COP N/A
- Revenue Next Year
- GILD $0.36
- COP $9.85
- P/E Ratio
- GILD $929.26
- COP $11.50
- Revenue Growth
- GILD 3.31
- COP N/A
- 52 Week Low
- GILD $62.07
- COP $94.23
- 52 Week High
- GILD $98.90
- COP $135.18
- Technical
- Relative Strength Index (RSI)
- GILD 57.65
- COP 30.54
- Support Level
- GILD $90.27
- COP $94.23
- Resistance Level
- GILD $94.05
- COP $97.19
- Average True Range (ATR)
- GILD 1.99
- COP 1.91
- MACD
- GILD 0.07
- COP -0.36
- Stochastic Oscillator
- GILD 82.30
- COP 21.95
About GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
About COP ConocoPhillips
ConocoPhillips is a US-based independent exploration and production firm. In 2023, it produced 1.2 million barrels per day of oil and natural gas liquids and 3.1 billion cubic feet per day of natural gas, primarily from Alaska and the Lower 48 in the United States and Norway in Europe and several countries in Asia-Pacific and the Middle East. Proven reserves at year-end 2023 were 6.8 billion barrels of oil equivalent.